# SANDRIL
> **NDA010012** · New Drug Application · Sponsor: LILLY · Approved 1981-10-22
## Drug
- **FDA Application Number:** NDA010012
- **Application type:** New Drug Application
- **Brand name:** SANDRIL
- **Generic name:** Reserpine
- **Active ingredients:** RESERPINE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** LILLY
- **First approval:** 1981-10-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010012)
---
*MORVS · CC0 1.0*